Jason Mills


This Top Analyst Says Avinger Inc (AVGR) Must Find a Buyer ASAP

Avinger Inc (NASDAQ:AVGR) released second-quarter earnings last evening that have left top analyst Jason Mills at Canaccord firmly on the sidelines. While the …

Top Analyst Lifts Price Target for Intuitive Surgical, Inc. (ISRG) on Back of Strong 2Q Results

Canaccord analyst Jason Mills is out today with a bullish research note on Intuitive Surgical, Inc. (NASDAQ:ISRG), cheering the company’s strong second-quarter results.

Novadaq Technologies Inc. (NVDQ) Acquisition Could Spark a Bidding War

Yesterday, Novadaq Technologies Inc.(NASDAQ:NVDQ) shares skyrocketed 95% after the company announced it entered an ultimate agreement with Stryker Corp.

Canaccord Sees Compelling Value in Novadaq Technologies Inc (NVDQ) Shares

Novadaq Technologies Inc (NASDAQ:NVDQ) shares are rising close to 5% as the medical imaging solutions maker stands to benefit from receiving reimbursement coverage from …

Canaccord Analyst Recommends Investors to Stay on the Sidelines on Endologix, Inc. (ELGX); Shares Dive 27%

Endologix, Inc. (NASDAQ:ELGX) shares plunged almost 27% today after today’s announcement that the medical-device maker has placed AFX/AFX2 endografts on a temporary shipping …

Bull of the Day: Canaccord Raises Price Target for HeartWare International Inc (HTWR)

Shares of HeartWare International Inc (NASDAQ:HTWR) jumped over 90% today, following the news that the heart-failure device maker agreed to be bought by Medtronic PLC (NYSE:MDT) …

Canaccord Maintains Buy on Sunshine Heart Inc Following FDA Approval Of COUNTER HF Protocol Amendment

Canaccord analyst Jason Mills weighed in today with a favorable report on Sunshine Heart Inc (NASDAQ:SSH), after the company announced that the FDA has approved an …

Canaccord Slashes Price Target for Sunshine Heart Inc, But Remains Positive

In a research report released today, Canaccord analyst Jason Mills reiterated a Buy rating on shares of Sunshine Heart Inc (NASDAQ:SSH), but reduced the price …

Canaccord Reiterates Buy on Sunshine Heart Inc Following FDA Review of IDE Supplement

Canaccord’s healthcare analyst Jason Mills weighed in with an optimistic view on Sunshine Heart Inc (NASDAQ:SSH), following the news that the FDA responded to the company’s IDE …

Canaccord Pounds the Table on Sunshine Heart Inc

Canaccord Genuity analyst Jason Mills was out pounding the table on Sunshine Heart Inc (NASDAQ:SSH) Thursday, reiterating a Buy rating and a $7.50 price target, which represents a potential …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts